STRO

STRO

USD

Sutro Biopharma Inc. Common Stock

$1.100+0.000 (0.000%)

实时价格

Healthcare
生物技术
美国

价格图表

Loading Chart...

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$1.100

最高价

$1.110

最低价

$1.030

成交量

0.07M

公司基本面

市值

92.2M

所属行业

生物技术

国家/地区

United States

交易统计

平均成交量

1.85M

交易所

NGM

货币

USD

52周价格范围

最低价 $0.52当前价 $1.100最高价 $5.17

相关新闻

GlobeNewswire

Sutro Biopharma to Participate in Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ:STRO), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs),

查看更多
Sutro Biopharma to Participate in Upcoming Investor Conferences
PR Newswire

New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty

Equity Insider News Commentary – Optimism in the field of oncology is on the rise, thanks to the National Institutes of Health's latest annual...

查看更多
New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty
Analyst Upgrades

HC Wainwright & Co. Reiterates Neutral on Sutro Biopharma, Maintains $2 Price Target

HC Wainwright & Co. analyst Andres Maldonado reiterates Sutro Biopharma with a Neutral and maintains $2 price target.

查看更多
HC Wainwright & Co. Reiterates Neutral on Sutro Biopharma, Maintains $2 Price Target
GlobeNewswire

Sutro Biopharma to Highlight its Next-Generation Exatecan and Dual-Payload ADC Programs in Presentations at AACR 2025

SOUTH SAN FRANCISCO, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ:STRO), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs),

查看更多
Sutro Biopharma to Highlight its Next-Generation Exatecan and Dual-Payload ADC Programs in Presentations at AACR 2025